Weight Management Hub

Body mass index

(kg/m²)

Macronutrient need calculator

Types of tummies

The evidence behind DRV+

Weight Management

Why weight management gets harder and what women want

Our survey of 1,030 adults reveals why weight becomes so much harder to manage with age and a clear appetite for natural, evidence-based support over medication.

1,030 respondents

2024–2025

Cross-sectional customer survey

76% find weight hard to manage

69% of menopausal women find it harder

60%+ would choose a natural supplement

Study Findings

We surveyed 1,030 adults on weight perception, the barriers they face, the role of menopause and sleep, and their attitudes to GLP-1 medication versus natural supplements.

What we found:

76.1% find weight hard to manage, despite 79.3% actively trying to manage their weight, and most exercising regularly. The menopausal transition was the single biggest factor, 68.8% of peri-, meno- and postmenopausal women found weight 'a lot harder' with age (versus 44.1% of other women), concentrated in the 40s and 50s and around the middle. Cravings, sweet tooth and emotional eating outranked cost and time in challenges to managing weight, and 60.1% would choose a natural, clinically proven supplement, though 60.8% didn't realise such options exist.

What This Means

Menopause is the turning point

68.8% of menopausal women find weight management 'a lot harder' with age.

A near 25-point jump versus other women - peaking in the 40s and 50s.

It's about cravings, not willpower

64.7% cite cravings or emotional eating as their biggest barrier.

Appetite and emotion outrank practical barriers like cost and time.

Clear demand for natural support

60.1% would choose a natural supplement over GLP-1 medication.

Yet 60.8% don't realise effective options already exist.

Read the abstract

Why menopausal weight gain happens

Reduced calorie burn

Hormone changes plus loss of lean mass contribute to a drop in how many calories the body burns at rest. If diet and physical activity stay the same, this energy gap leads to weight gain.1

Increased abdominal fat

Perimenopausal women show measurable increases in waist size (central adiposity) even over relatively short periods.2

Changes in fat distribution

Oestrogen helps regulate fat distribution (favouring more peripheral / subcutaneous fat), promotes insulin sensitivity, and helps with energy balance. Once oestrogen declines, there is a shift toward visceral fat accumulation and less insulin sensitivity.1

Lifestyle & sleep changes

Changes in physical activity (often decreasing), dietary habits, sleep disturbances, stress, etc. tend to exacerbate the tendency to gain weight.3

Altered appetite regulation

Hormones that regulate appetite / energy expenditure (e.g. leptin, adiponectin) are affected. Some studies show changes in leptin and adiponectin levels during menopausal transition.4

Increased insulin resistance

Insulin resistance tends to increase, making it easier for the body to store fat and harder to lose fat.5

Understanding and managing menopausal weight gain

Menopause-associated weight gain is driven by ovarian oestrogen loss, which alters adipose distribution and function, reduces muscle mass and energy expenditure, worsens insulin sensitivity, and interacts with sleep and vasomotor symptoms and behaviour, together promoting increased visceral adiposity and metabolic risk.6

Factor

How it contributes to weight gain

How to manage it

Hormonal changes (decline in oestrogen)

Shifts fat storage to the abdomen, reduces metabolic rate

Balanced diet with protein and fibre, phytoestrogen-rich foods, regular exercise

Muscle loss (sarcopaenia)

Lowers resting metabolic rate

Strength training, adequate protein intake

Slower metabolism

Fewer calories burned at rest

Portion control, focus on nutrient-dense foods

Sleep disturbances

Poor sleep increases cravings and hunger hormones

Good sleep hygiene, relaxation techniques

Stress and cortisol

Promotes abdominal fat gain

Stress management (yoga, meditation, breathing)

Insulin resistance

Increased fat storage, especially visceral fat

Lower refined carbohydrates, balance blood sugar

Hormonal changes (decline in oestrogen)

How it contributes to weight gain Shifts fat storage to the abdomen, reduces metabolic rate

How to manage it Balanced diet with protein and fibre, phytoestrogen-rich foods, regular exercise

Muscle loss (sarcopaenia)

How it contributes to weight gain Lowers resting metabolic rate

How to manage it Strength training, adequate protein intake

Slower metabolism

How it contributes to weight gain Fewer calories burned at rest

How to manage it Portion control, focus on nutrient-dense foods

Sleep disturbances

How it contributes to weight gain Poor sleep increases cravings and hunger hormones

How to manage it Good sleep hygiene, relaxation techniques

Stress and cortisol

How it contributes to weight gain Promotes abdominal fat gain

How to manage it Stress management (yoga, meditation, breathing)

Insulin resistance

How it contributes to weight gain Increased fat storage, especially visceral fat

How to manage it Lower refined carbohydrates, balance blood sugar

How menopause changes body composition and metabolism

Loss of oestrogen altered adipose distribution and adipocyte biology

Mechanism: Circulating 17β-oestradiol acts via ERα/ERβ in adipose tissue to regulate preadipocyte differentiation, lipolysis, lipogenesis and local inflammation. With menopause, systemic oestradiol falls and adipose aromatisation becomes more important; the balance of signalling shifts and promotes adipocyte hypertrophy, reduced subcutaneous (gluteofemoral) fat storage capacity and preferential accumulation of visceral adipose tissue.

Consequences: Increased visceral adipose tissue is metabolically active (proinflammatory cytokines, free fatty acid flux), raising cardiometabolic risk even if overall BMI change is modest.6

Reduced lean mass leads to lower resting energy expenditure

Mechanism: Oestradiol supports muscle mass and mitochondrial function. Menopausal ovarian failure accelerates loss of type II fibres and promotes sarcopaenic changes (reduced muscle protein synthesis, increased proteolysis), lowering resting energy expenditure and total daily energy expenditure. Even small declines in lean mass progressively reduce caloric needs and predispose to positive energy balance if intake / activity don’t adjust.7

Insulin resistance, hepatic steatosis and dysregulated lipid metabolism

Mechanism: Oestrogen improves insulin signalling (PI3K/Akt pathway effects, GLUT4 expression) and hepatic lipid handling. Declining oestrogen is associated with increased peripheral and hepatic insulin resistance, higher fasting insulin and increased de novo lipogenesis in the liver. This promotes visceral fat accrual and non-alcoholic fatty liver disease (NAFLD/MASLD) risk.8

Appetite, macronutrient handling and the protein / leverage effects

Mechanism: Menopause may alter appetite regulation (hypothalamic leptin / ghrelin sensitivity, reward circuitry), and increased protein catabolism or altered satiety signalling can change food choices and portion sizes. Some recent work suggests altered protein turnover during the transition may drive increased energy intake to meet protein needs (the ‘protein leverage’ hypothesis), contributing to weight gain.9

Vasomotor symptoms, sleep disturbance and reduced activity

Mechanism: Hot flashes and night sweats and the resultant broken sleep increase sympathetic tone and cortisol, impair glucose regulation, increase appetite and cravings, and reduce daytime activity. Over time, these factors favour weight gain and central fat deposition. Studies show that vasomotor symptom frequency and persistence correlate with later weight gain.10

Adipose tissue dysfunction low-grade inflammation

Mechanism: Postmenopausal subcutaneous adipose tissue and visceral adipose tissue show increased immune cell infiltration, hypoxia, fibrosis and proinflammatory cytokine expression; this adipose dysfunction amplifies insulin resistance and metabolic risk beyond what body weight alone would predict.11

Clinical implications

Mechanism: Don’t assume BMI alone. Measure and record waist circumference and consider a body composition scan if available to detect visceral fat gain and lean mass loss. Screen for metabolic syndrome (fasting glucose/HbA1c, lipids, LFTs).11

Key metabolic consequences of increased abdominal fat

Insulin resistance and type 2 diabetes

VAT releases free fatty acids directly into the portal circulation, leading to hepatic insulin resistance, impaired glucose metabolism and increased risk of type 2 diabetes.

Dyslipidaemia: Higher triglycerides, reduced HDL and more small dense LDL leading to an atherogenic lipid profile.
Non-alcoholic fatty liver disease (NAFLD/MASLD): Excess fat deposition in the liver due to increased free fatty acid flux.

Cardiovascular consequences

Hypertension: VAT increases activation of the renin-angiotensin system, raising blood pressure.
Atherosclerosis and coronary artery disease: Pro-inflammatory cytokines (IL-6, TNF-α) and adipokines (resistin, leptin dysregulation) promote vascular inflammation and plaque formation.
Stroke and heart failure: Abdominal obesity is an independent predictor of cerebrovascular and heart failure risk.

Hormonal and inflammatory consequences

Low-grade chronic inflammation: VAT secretes cytokines and recruits immune cells, driving systemic inflammation.
Altered adipokine secretion: Lower adiponectin (protective) and increased leptin (resistance develops), worsening insulin resistance and inflammation.
Pro-thrombotic state: Elevated plasminogen activator inhibitor-1 (PAI-1), increasing clotting risk.

Cancer risk

Increased risk of postmenopausal breast cancer, colorectal cancer and endometrial cancer, partly via oestrogen production from VAT aromatase and chronic inflammation.

Musculoskeletal and quality of life consequences

Sarcopaenic obesity: Loss of lean mass combined with visceral fat increases frailty and reduces physical function.
Joint problems: Increased load on knees / hips, higher osteoarthritis risk.
Sleep apnoea: Abdominal fat worsens airway collapsibility and sleep quality.

Dietary recommendations for belly fat

Foods to reach for

Foods to avoid

Learn More

Weight Management Support

Weight Management Support is built around Metabolaid®, a patented extract of lemon verbena leaf and hibiscus flower backed by eight clinical trials over 20 years. We use 500mg, the dose tested in those trials. Paired with green tea extract standardised to 95% polyphenols (equivalent to 3,000mg green tea, supplying EGCG) and chromium, clinically proven to support normal blood glucose and macronutrient metabolism.